Table 4

Prevalence ratios of prevalent erectile dysfunction by inflammatory biomarkers after propensity score matching, National Health and Nutrition Examination Survey 2001-2004.

Model 1aModel 2bModel 3c
aOR (95% CI)PaOR (95% CI)PaOR (95% CI)P
SII1.00 (1.00, 1.00).1311.00 (1.00, 1.00).1251.00 (1.00, 1.00).102
NLR1.10 (1.00, 1.21).049d1.10 (1.00, 1.22).044d1.11 (1.01, 1.23).034d
PLR1.00 (1.00, 1.00).038d1.00 (1.00, 1.00).040d1.00 (1.00, 1.00).035d
LMR0.91 (0.84, 0.97).010d0.90 (0.83, 0.97).008d0.90 (0.83, 0.97).007d
SIRI21.03 (0.01, 3.24 × 106).48122.63 (0.01, 4.51 × 106).47725.79 (0.01, 7.14 × 106).472
Model 1aModel 2bModel 3c
aOR (95% CI)PaOR (95% CI)PaOR (95% CI)P
SII1.00 (1.00, 1.00).1311.00 (1.00, 1.00).1251.00 (1.00, 1.00).102
NLR1.10 (1.00, 1.21).049d1.10 (1.00, 1.22).044d1.11 (1.01, 1.23).034d
PLR1.00 (1.00, 1.00).038d1.00 (1.00, 1.00).040d1.00 (1.00, 1.00).035d
LMR0.91 (0.84, 0.97).010d0.90 (0.83, 0.97).008d0.90 (0.83, 0.97).007d
SIRI21.03 (0.01, 3.24 × 106).48122.63 (0.01, 4.51 × 106).47725.79 (0.01, 7.14 × 106).472

Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PIR, poverty impact ratio; PLR, platelet-to-lymphocyte ratio; SII, systemic immune-inflammatory index; SIRI, systemic inflammation response index.

a

Model 1 is unadjusted.

b

Model 2 adjusted for age, race, BMI, smoking, education, and PIR.

c

Model 3 adjusted for model 2 covariates and for hypertension, diabetes, and glomerular filtration rate.

d

Statistical difference.

Table 4

Prevalence ratios of prevalent erectile dysfunction by inflammatory biomarkers after propensity score matching, National Health and Nutrition Examination Survey 2001-2004.

Model 1aModel 2bModel 3c
aOR (95% CI)PaOR (95% CI)PaOR (95% CI)P
SII1.00 (1.00, 1.00).1311.00 (1.00, 1.00).1251.00 (1.00, 1.00).102
NLR1.10 (1.00, 1.21).049d1.10 (1.00, 1.22).044d1.11 (1.01, 1.23).034d
PLR1.00 (1.00, 1.00).038d1.00 (1.00, 1.00).040d1.00 (1.00, 1.00).035d
LMR0.91 (0.84, 0.97).010d0.90 (0.83, 0.97).008d0.90 (0.83, 0.97).007d
SIRI21.03 (0.01, 3.24 × 106).48122.63 (0.01, 4.51 × 106).47725.79 (0.01, 7.14 × 106).472
Model 1aModel 2bModel 3c
aOR (95% CI)PaOR (95% CI)PaOR (95% CI)P
SII1.00 (1.00, 1.00).1311.00 (1.00, 1.00).1251.00 (1.00, 1.00).102
NLR1.10 (1.00, 1.21).049d1.10 (1.00, 1.22).044d1.11 (1.01, 1.23).034d
PLR1.00 (1.00, 1.00).038d1.00 (1.00, 1.00).040d1.00 (1.00, 1.00).035d
LMR0.91 (0.84, 0.97).010d0.90 (0.83, 0.97).008d0.90 (0.83, 0.97).007d
SIRI21.03 (0.01, 3.24 × 106).48122.63 (0.01, 4.51 × 106).47725.79 (0.01, 7.14 × 106).472

Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PIR, poverty impact ratio; PLR, platelet-to-lymphocyte ratio; SII, systemic immune-inflammatory index; SIRI, systemic inflammation response index.

a

Model 1 is unadjusted.

b

Model 2 adjusted for age, race, BMI, smoking, education, and PIR.

c

Model 3 adjusted for model 2 covariates and for hypertension, diabetes, and glomerular filtration rate.

d

Statistical difference.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close